Anodyne Therapy, LLC

Study demonstrates restoration of sensation in peripheral neuropathy

Published in Pharma Law Weekly, April 26th, 2005

Anodyne Therapy, LLC, announced the publication of a sixth peer-reviewed clinical study demonstrating restoration of sensation in the feet of patients with peripheral neuropathy.

The purpose of the study was to measure improvements in patients' ability to feel a standardized 10 gram Semmes-Weinstein Monofilament (SWM) test - the test deemed by Medicare in a 2001 Decision Memorandum to be the best measure of risk for diabetic ulcers amputations.

The study appears in the March/April 2005 issue of The Journal of the American Podiatric Medical Association.

Previous studies have shown that sensory impairments due to peripheral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-04-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry